Dorsey Wright & Associates’s Dr. Reddy's Laboratories RDY Stock Holding History

Dorsey Wright & Associates’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-314,140	Closed	-$4.48M	–	361
2020 Q4	$4.48M	Sell	314,140 -5,920	-2%	-$79.7K	0.66%	31
2020 Q3	$4.45M	Buy	320,060 +3,705	+1%	+$44.2K	0.8%	25
2020 Q2	$3.33M	Sell	316,355 -27,285	-8%	-$278K	0.68%	40
2020 Q1	$2.77M	Sell	343,640 -39,220	-10%	-$327K	1.05%	40
2019 Q4	$3.11M	Sell	382,860 -15,920	-4%	-$126K	1.03%	32
2019 Q3	$3.02M	Sell	398,780 -5,740	-1%	-$42.7K	0.76%	70
2019 Q2	$3.03M	Buy	+404,520	New	+$3.18M	0.74%	69

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dorsey Wright & Associates's RDY Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 314,140 shares — an estimated $4.48M sold.

Dorsey Wright & Associates first reported a position in RDY in Q2 2019 and held it in 7 quarters. The position peaked at $4.48M in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

Dorsey Wright & Associates reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
Dorsey Wright & Associates sold 314,140 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $4.48M.
Dorsey Wright & Associates first reported a position in Dr. Reddy's Laboratories in Q2 2019 and held it in 7 quarters.
Dorsey Wright & Associates's Dr. Reddy's Laboratories position peaked at $4.48M in Q4 2020.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.